Mirae Asset Global Investments’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-94,437
| Closed | -$4.43M | – | 1942 |
|
|
2024
Q1 | $4.43M | Buy |
94,437
+13,294
| +16% | +$624K | 0.01% | 924 |
|
|
2023
Q4 | $3.75M | Sell |
81,143
-12,690
| -14% | -$587K | 0.01% | 991 |
|
|
2023
Q3 | $3.82M | Buy |
93,833
+8,098
| +9% | +$329K | 0.01% | 940 |
|
|
2023
Q2 | $4.16M | Sell |
85,735
-8,702
| -9% | -$422K | 0.01% | 943 |
|
|
2023
Q1 | $4.65M | Sell |
94,437
-31,965
| -25% | -$1.58M | 0.01% | 880 |
|
|
2022
Q4 | $6.4M | Sell |
126,402
-6,396
| -5% | -$324K | 0.02% | 746 |
|
|
2022
Q3 | $6.67M | Sell |
132,798
-15,210
| -10% | -$763K | 0.02% | 712 |
|
|
2022
Q2 | $7.24M | Sell |
148,008
-11,373
| -7% | -$556K | 0.02% | 716 |
|
|
2022
Q1 | $9.58M | Sell |
159,381
-279,915
| -64% | -$16.8M | 0.02% | 678 |
|
|
2021
Q4 | $34.9M | Sell |
439,296
-34,583
| -7% | -$2.75M | 0.07% | 304 |
|
|
2021
Q3 | $42.1M | Buy |
473,879
+227,850
| +93% | +$20.2M | 0.11% | 235 |
|
|
2021
Q2 | $24.5M | Sell |
246,029
-29,878
| -11% | -$2.97M | 0.07% | 351 |
|
|
2021
Q1 | $24.8M | Buy |
275,907
+200,737
| +267% | +$18.1M | 0.09% | 298 |
|
|
2020
Q4 | $7.13M | Buy |
75,170
+25,087
| +50% | +$2.38M | 0.03% | 581 |
|
|
2020
Q3 | $3.6M | Buy |
+50,083
| New | +$3.6M | 0.02% | 619 |
|